Consolidated Portfolio Review Corp’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio THQ Stock Details THQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-53,518	Closed	-$1.18M	–	393
2024 Q3	$1.18M	Buy	53,518 +874	+2%	+$18.7K	0.26%	93
2024 Q2	$1.07M	Buy	52,644 +6,637	+14%	+$132K	0.25%	98
2024 Q1	$925K	Buy	46,007 +18,041	+65%	+$347K	0.24%	106
2023 Q4	$506K	Buy	27,966 +11,949	+75%	+$202K	0.12%	173
2023 Q3	$272K	Buy	16,017 +1,505	+10%	+$28K	0.07%	254
2023 Q2	$277K	Buy	+14,512	New	+$273K	0.07%	248

Other funds holding THQ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HBCM

Heron Bay Capital Management Bloomfield Hills, Michigan $1.08B AUM 7.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Consolidated Portfolio Review Corp's THQ Position: Q4 2024 in Review

Consolidated Portfolio Review Corp sold out of abrdn Healthcare Opportunities Fund (THQ) in Q4 2024, closing a stake of 53,518 shares — an estimated $1.18M sold.

Consolidated Portfolio Review Corp first reported a position in THQ in Q2 2023 and held it in 6 quarters. The position peaked at $1.18M in Q3 2024. 106 funds tracked by Wall St. Rank hold THQ as of Q4 2024.

Consolidated Portfolio Review Corp reported no remaining abrdn Healthcare Opportunities Fund position as of Q4 2024 after selling out during the quarter.
Consolidated Portfolio Review Corp sold 53,518 abrdn Healthcare Opportunities Fund shares in Q4 2024, an estimated $1.18M.
Consolidated Portfolio Review Corp first reported a position in abrdn Healthcare Opportunities Fund in Q2 2023 and held it in 6 quarters.
Consolidated Portfolio Review Corp's abrdn Healthcare Opportunities Fund position peaked at $1.18M in Q3 2024.
106 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q4 2024.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2024, filed 27 Jan 2025.